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Abstract There has been a clear decline in the volume of
oxygen in Earth’s atmosphere over the past 20 years.
Although the magnitude of this decrease appears small
compared to the amount of oxygen in the atmosphere, it is
difficult to predict how this process may evolve, due to the
brevity of the collected records. A recently proposed model
predicts a non-linear decay, which would result in an
increasingly rapid fall-off in atmospheric oxygen concen-
tration, with potentially devastating consequences for
human health. We discuss the impact that global deoxy-
genation, over hundreds of generations, might have on
human physiology. Exploring the changes between differ-
ent native high-altitude populations provides a paradigm of
how humans might tolerate worsening hypoxia over time.
Using this model of atmospheric change, we predict that
humans may continue to survive in an unprotected atmo-
sphere for *3600 years. Accordingly, without dramatic
changes to the way in which we interact with our planet,
humans may lose their dominance on Earth during the next
few millennia.
Keywords Oxygen  Hypoxia  Acclimatization 
Physiological adaptation
Introduction
Human dominion over planet Earth is driving profound
changes that may culminate in extinction. Loss of natural
vegetation and the burning of fossil fuels are altering our
atmosphere at an alarming rate [1]. Two interconnected
themes have received the most attention: the accelerated
rise in atmospheric carbon dioxide concentration and the
escalation of global temperatures. These changes are
accompanied by natural phenomena with potentially
catastrophic consequences, such as increasingly unpre-
dictable climate subsystems and rising sea levels from
polar ice cap recession [2–4]. If such environmental haz-
ards were not a sufficient threat to the survival of Earth’s
7 billion plus human inhabitants, there is yet another
concerning change already underway, global deoxygena-
tion. Although the current volume of oxygen in our
atmosphere is vast, it is diminishing inexorably, and yet
this does not appear to be a priority for environmental
concern. While the dynamics of oxygen decline is highly
contentious, a new model of its nonlinear nature predicts
total oxygen depletion within several thousand years [5].
This disruption of Earth’s fragile ecosystem could be the
final straw for humans and the many other forms of life that
rely on oxygen to generate energy. Here we discuss the
biological significance of atmospheric oxygen, the pro-
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Oxygen and Earth’s atmosphere
Molecular oxygen (O2) is arguably one of the most
important elements on Earth, particularly for the aerobic
organisms that depend on it to release energy from carbon-
based macromolecules. The concentration of oxygen in the
atmosphere is 20.95% (209,460 ppm) but this has fluctu-
ated markedly throughout history (Fig. 1). Earth is
*4.5 billion years old, and its early atmosphere contained
virtually no oxygen whatsoever. The primitive atmosphere
was instead formed mainly of hydrogen, with traces of
methane and ammonia. Volcanoes then leached nitrogen
and carbon dioxide into this mixture but it was not until the
‘great oxygenation event,’ *2.3 billion years ago, that
oxygen was released into the atmosphere by cyanobacteria
that used carbon dioxide and sunlight to generate energy
via photosynthesis [6, 7]. As photosynthesizing cells spread
across the planet, they eventually developed into complex
multi-cellular complex plants. This crucial event in the
developing ecosystem changed the world from a barely
habitable rock into the luscious green environment that we
recognize today. Over time, oxygen became the predomi-
nant mechanism for energy to be generated by non-pho-
tosynthesizing cells, through oxidative phosphorylation in
mitochondria. As billions of years passed by, an equilib-
rium was established whereby the concentration of oxygen
fluctuated within a habitable range, between about 15 and
35%, which has been maintained from the beginning of the
Cambrian period 540 million years ago until the present
day (Fig. 1). Each surge in the atmosphere’s oxygen con-
centration was accompanied by a new burst of life, while
the troughs were associated with downscaling and extinc-
tion of species. The oscillation of the atmospheric oxygen
concentration around a level that optimally promotes the
development of multicellular organisms is termed the
global oxygen cycle [8]—but what are the margins for the
existence of complex life on Earth, particularly humans?
As global deoxygenation is a reality, understanding the
impact of declining atmospheric oxygen on human physi-
ology is of increasing importance. Defining the lower limit
of atmospheric oxygen compatible with human survival
will inform predictions of how long our species can persist
on a planet undergoing progressive asphyxiation.
The decline in global oxygen concentration
Since 1989, detailed recordings from atmospheric air
have been taken in order to monitor global concentra-
tions of carbon dioxide and oxygen. Observational
records of atmospheric oxygen concentration from sev-
eral stations around the globe are maintained within the
Scripps Institute Oxygen Programme (http://scrippso2.
ucsd.edu/). Oxygen measurements are reported as chan-
ges in the oxygen/nitrogen (O2/N2) ratio of sampled air
relative to a reference (air pumped in the mid-1980s and
stored in the Scripps laboratory). The unit for these
measurements is ‘‘per meg’’, which means that a decline
of 1 per meg is equivalent to a 0.0001% decline of
oxygen concentration. Put another way, 1 per meg
indicates one molecule out of 1,000,000 oxygen mole-
cules, or roughly one molecule in 4.8 million molecules
of air. Because natural variation of nitrogen concentra-
tion is much smaller than that for oxygen and its con-
centration is much higher, changes in O2/N2 ratio
primarily reflect changes in oxygen concentration [9].
According to the Scripps Institute, the oxygen concen-
tration is currently declining by *19 per meg per year,
equivalent to 4 ppm per year (Fig. 2).
From the original Scripps Institute data, it was hypoth-
esized that the decline in atmospheric oxygen concentra-
tion was linear, however, as the dataset grows, it has been
proposed that this may not be the case. One possible sce-
nario is a parabolic decline [5]. Because the observed
records span only a few decades, projection of this decay is
highly uncertain and the complexity of the biogeochemical
interactions makes such a projection a challenging task.
However, this new mathematical model proposes that the
horizon of oxygen decline will be reached much sooner
than previously estimated from a linear model, leaving
only a few thousand years until total oxygen depletion [5].
If we apply this parabolic projection to the currently
available observed data, it predicts that the concentration of
oxygen in the atmosphere will reach zero in *4400 years,
passing beyond the halfway point in *3600 years (Fig. 2).
The dynamics of the oxygen decline is approximated by
using a stochastic model:
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Fig. 1 Approximate change in the concentration of oxygen in Earth’s
atmosphere over the last 4 billion years [7]
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Here, trend T(t) is a real-valued function, U(t) is a sta-
tionary generalized random process, and s(t) is a positive
real-valued smooth function used to model the
heteroscedasticity of the error term. As an example,
U(t) can be continuous autoregressive moving average
random process of order (p, q). The model realistically
reproduces oxygen data as a combination of a declining
global trend, seasonal periodicity, and smaller-scale fluc-
tuations of higher frequency. This oscillating decline can
be clearly seen in the Scripps Institute data (Fig. 2) and
hypotheses to explain it have been previously been pre-
sented [10].
Why is atmospheric oxygen concentration
declining?
Earth’s atmosphere, like most biological systems, is in a
constant state of flux governed by oxygen’s generation and
destruction; natural processes that surround us every day
(Fig. 3). The primary source of oxygen on Earth is pho-
tosynthesis, the generation of carbohydrates from carbon
dioxide and water using sunlight as a catalyst (Eq. 1).
Higher plants, algae, cyanobacteria, and prochlorophytes
are all capable of photosynthesis. A tiny amount of
molecular oxygen is also produced by the photolysis of
water vapor in the upper atmosphere (Eq. 2). The end-users
of molecular oxygen are aerobic life forms, including
humans, which use it to generate the majority of their
energy requirements (Eq. 3). Oxygen is also used during
photorespiration, in which organic substrates are oxidized
to yield ATP for energetic processes, in some photosyn-
thesizing cells. The atmosphere and sea act as the main
reservoirs for oxygen and major events such as natural fires
can alter the balance to a minor degree. Therefore, in
simple terms, if the number of plants decreases, the oxy-
gen-generating capacity of the Earth is reduced; and if the
number of animals (including humans) increases, then
oxygen consumption will rise. Combustion of fossil fuels
has a major impact on oxygen and carbon dioxide levels in
the atmosphere, there being a correlation between fossil
fuel-related global warming and depletion of oxygen from
the oceans [11]. Furthermore, oxygen is consumed not only
when fossil fuels are used in combustion, so the relation
between decline of oxygen and rise in carbon dioxide is not
linear. For example, oxygen is consumed in many oxida-
tion processes in industry for materials manufacturing,
where there is no direct combustion of fossil fuels. One of
the uncertain factors in the model of oxygen decline lies in
the rise of new technologies, which may appear ‘‘green’’ in
terms of carbon dioxide emissions but at the same time
would deplete oxygen—these need to be monitored in the
context of the atmospheric oxygen decline. Waning of
atmospheric oxygen concentration will also have knock-on
effects in the oceans. Henry’s law determines the amount
of gas that dissolves into a liquid and as the atmospheric
partial pressure of oxygen (PatO2) declines, oxygen will
diffuse out of the water leading to further oceanic
Fig. 2 a The change in oxygen
concentration ration over time
recorded at ‘Alert Station’ in
Canada, with a parabolic fitted
decay curve [9]. b The projected
decline based in oxygen
concentration over time, using
data from nine recording station
in the Scripps Programme [9].
The uncertainty of the
projection, based on the nine
observational records around
the globe, is shown in the grey
shaded area. The red dotted line
denotes lowest oxygen
concentration likely to be
tolerated by humans and time
from now at which this will
occur. Both figures reproduced
with permission from [9]
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deoxygenation, depriving the underwater world of the
oxygen it requires to survive. It has been estimated that
*70% of atmospheric oxygen is produced in the oceans by
photosynthesis in phytoplankton [12]. There is concern that
uncontrolled global warming could lead to a catastrophic
loss of this vital source of atmospheric oxygen through
inhibition of photosynthesis [13].
Photosynthesis:
6CO2 + 6H2O ! 6O2 + C6H12O6: ð1Þ
Photolysis:
2H2O ! 4Hþ + e + O2: ð2Þ
Aerobic metabolism:
C6H12O6 + 6O2 ! 6CO2 + 6H2O: ð3Þ
Biological impact of atmospheric deoxygenation
The biological effect of a gas is determined by its partial
pressure, which, according to Dalton’s law, is equal to the
product of barometric pressure and the fractional concen-
tration of the gas in the mixture (Eq. 4). For example, at
sea level, PatO2 is *21 kPa (sea level barometric pressure
101 kPa 9 fractional concentration of oxygen 0.21). Thus,
atmospheric hypoxia may result from either a decline in
oxygen concentration (normobaric hypoxia) or a reduction
in barometric pressure (hypobaric hypoxia). Differences in
the biological responses to these situations are subtle but
not completely insignificant [14]. For humans, the principal
consequence of a fall in PatO2 is hypoxemia (a lack of
oxygen in the blood), resulting in reduced delivery of
oxygen to the tissues (tissue hypoxia). This occurs during
ascent to high altitude, due to the exponential decline in
barometric pressure. Above *1500–2500 m, depending
upon the individual, hypoxemia can lead to altitude-related
illnesses, such as acute mountain sickness (AMS).
Hypoxemia and tissue hypoxia can also result from many
pathophysiological states that impair oxygen transport,
such as respiratory and cardiovascular diseases. Humans
have the ability to adapt to hypoxemia, through a process
known as acclimatization, but the extent to which adapta-
tion can compensate for the oxygen deficit depends on the
magnitude of the deficit, and the time over which it occurs.
Partial pressure of gas A ¼ barometric pressure
 fractional concentration of gas A: ð4Þ
Adaptation to acute hypoxia
No clear definitions exist to define time-related exposures
to hypoxia, but attempts have been made to unify the
language used [15]. A significant and abrupt fall in PatO2
cannot be tolerated for more than a few minutes before
cerebral hypoxia results in unconsciousness. Descriptions
of death following sudden oxygen deprivation were com-
mon amongst early high-altitude aviators during World
War II [16]. The ‘‘time for useful consciousness’’ on sud-
den exposure to a simulated altitude of 7620 m above sea
level (PatO2 *8 kPa) is *4–5 min) [17]. The rapidity of
the fall in PatO2 prevents any meaningful adaptation
beyond hyperventilation and tachycardia, a desperate
attempt to increase circulating blood oxygen levels. This
almost immediate physiological change is brought about
through oxygen sensing in the carotid bodies and their
subsequent effect on the respiratory and cardiovascular
centers of the brain.
Adaptation to subacute hypoxia
With a more gradual exposure to hypoxia, as might be
experienced by during a trek to high altitude, other bio-
logical systems have a chance to contribute through a
process known as acclimatization. In addition to aug-
mented ventilatory and cardiovascular responses, hypoxia
is sensed at a cellular level, triggering the increased
Fig. 3 Processes that influence
the global oxygen cycle and
therefore the atmospheric
concentration of oxygen
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concentration of a gene regulator known as hypoxia indu-
cible factor (HIF). The HIF complex up-regulates a variety
of specific genes, all pertinent to the survival of a sustained
hypoxic exposure (Fig. 4). This oxygen-sensing system is
one of the oldest and most robust cellular regulators and is
preserved throughout almost all life on Earth, signifying
the importance of the ability to rapidly respond to changes
in oxygen availability [18]. One important role of HIF is to
increase the number of circulating red blood cells through
the up-regulation of erythropoietin. This increases the
oxygen-carrying capacity of the blood over a period of
days to weeks and forms the backbone of short-term
hypoxic adaptation. It is through this process that the
summit of Mount Everest (8848 m), where PatO2 plum-
mets to 7 kPa, can be reached without the use of supple-
mental oxygen [19].
Lifelong hypoxic exposure
Chronic disease or long-term residence at high altitude can
expose humans to a lifetime of hypoxemia. *140 million
people live permanently at high altitude (conventionally
defined as [2500 m: the elevation that most people
demonstrate a drop in the oxygen saturation of hemoglobin,
SpO2) [20]; and whilst this is compatible with life, it is not
without consequences for many. With increasing altitude of
residence, chronic mountain sickness (CMS) and
intrauterine growth retardation (IUGR) become more
prevalent and an acceleration of pre-existing chronic res-
piratory diseases is observed [21]. Global atmospheric
deoxygenation would lead to such complications being
encountered at progressively lower elevations, and we
would expect their incidence and severity increase on a
global scale. CMS is characterized by excessive poly-
cythemia, progressing to pulmonary hypertension, right
ventricular failure, and death [22]. There is limited infor-
mation about the frequency of and mortality from this
disease in the present day as it is not a recognized classi-
fication in death certificates [21], but it will undoubtedly
generate a significant and progressive disease burden as
deoxygenation continues. The impact on human repro-
duction may have even more grave ramifications for pop-
ulation expansion and health. Fetal hypoxia, due to reduced
maternal oxygenation and uteroplacental blood flow,
reduces birth weight by an average of 100 g for every
Fig. 4 Examples of genes (in red) within the HIF pathway in which
positive selection has been identified in high-altitude populations.
Activation of the HIF response involves prolyl hydroxylases (PHD),
which, in the presence of oxygen, hydroxylates HIFa thus targeting it
for destruction by the ubiquitin–proteasome pathway. Under hypoxic
conditions, HIFa persists to combine with the constitutively present
HIFb, and this dimer acts as a transcription factor, influencing the
expression of over 100 genes, which possess hypoxia response
elements in their promoter regions, and play a role in the cellular and
systemic response to hypoxia. The HIF response involves increasing
oxygen delivery to hypoxic tissues (through effects on angiogenesis,
vascular tone, and erythropoiesis) as well as modifying cell
metabolism, proliferation, and survival pathways. High-altitude
positive selection has been demonstrated in all parts of this pathway,
but none of the alleles affected have been demonstrated in more than
one population. Data summarized from [31]. HIF hypoxia-inducible
factor, HRE hypoxia response elements, PHD prolyl hydroxylase
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1000 m above sea level [20, 23]. IUGR has wide-ranging
and severe consequences throughout life. Low birth
weights are linked to higher mortality in infancy, child-
hood, and later in life. Late (adult) morbidity and mortality
may be due to the heightened risk of systemic hyperten-
sion, coronary heart disease, and diabetes observed in low-
birth weight groups [24]. Decreasing PatO2 at altitude is
also associated with an increased prevalence of pre-
eclampsia, a syndrome of maternal hypertension and pro-
teinuria, which can progress to life-threatening seizures, as
well as IUGR [25]. Chronic lung disease follows an
accelerated course in hypoxic environments, resulting in a
shorter interval between onset and death, and further
increasing the incidence of right heart failure [26]. In short,
lifetime exposure to low PatO2 exerts detrimental effects
that may limit longevity, increase morbidity, and impair
human reproduction. However, some populations have
thrived at altitude and perhaps the survival of future gen-
erations of humans depends on the long-term adaptations
observed in these people.
Adaptation to hypoxia over generations
Populations that have occupied hypoxic environments for
hundreds of generations appear to have undergone genetic
adaptation leading to the expression of phenotypes that
convey an enhanced ability to survive and reproduce under
chronic hypoxic stress. Long-resident populations enjoy
reduced incidence and severity of the high-altitude com-
plications such as CMS and IUGR [20] compared to non-
ancestral high altitude residents, and their superior physical
performance at altitude is widely reported anecdotally and
demonstrated by increased maximal oxygen consumption
on exercise testing [27, 28].
Three populations have occupied highlands of
3500–4000 m above sea level for millennia. Current best
estimates place Tibetan plateau settlement first
(25,000 years ago) followed by that of the Andean Alti-
plano (12,000 years ago) with a range of values given for
colonization of the Ethiopian plateau (between 5000 and
70,000 years ago), although we cannot prove genetic
continuity between original colonizers and modern-day
populations [29]. Specific physiological traits, related to
the oxygen transport pathway or oxygen utilization, have
been identified in these populations, but the composite of
traits is different in each. For example, hemoglobin con-
centration is elevated in high-altitude Andeans, but remains
close to typical lowlander values at sea level in Tibetan and
Ethiopian highlanders up to altitudes of 4000 m, with only
minimal increment upon further ascent [30]. On the other
hand, SpO2 is lower in high-altitude Tibetans and Andeans
compared to Ethiopians [30]. Tibetan and Andean
highlanders have been the most extensively studied, with
comparatively limited information available about their
Ethiopian counterparts, and the main phenotypic differ-
ences between the three populations are summarized in
Table 1. There is a lack of consensus regarding some of
these differences, and we have much to learn about how
and to what extent each phenotype actually contributes to
improved function or survival in hypoxic conditions.
Many approaches have been applied to uncover the
genetic basis of these hypoxia-adapted phenotypes. High-
altitude populations appear to have undergone positive
selection in many genes that are involved in the HIF sig-
naling cascade, which co-ordinates the cellular and sys-
temic response to hypoxia. Examples of such genes are
summarized in Fig. 4. In most instances, the precise
function these genetic variants is yet to be revealed, but in
some instances, putative mechanisms are beginning to
emerge. For example, a variant of the EPAS1 gene (which
encodes the alpha subunit of the HIF-2 transcription factor)
has been demonstrated at increased frequency in high-
altitude Tibetans. The selected variant actually down-reg-
ulates HIF targets, including erythropoietin, and is associ-
ated with lower hemoglobin concentrations [31]. It has thus
been proposed that it may promote survival in hypoxic
conditions by protecting against CMS and improving
microcirculatory flow and local oxygen delivery due to
reduced blood viscosity. The Tibetans inherited this gene
from an ancient human race called the Denisovans, prior to
their extinction 40,000 years ago [32]. It has been identi-
fied in only one other population on Earth, the Han Chi-
nese, from which the Tibetans split less than 3000 years
ago. In this time, the frequency of the gene in the two
populations has diverged significantly: it is present in only
9% of Han but in 87% of Tibetans, the fastest known
example of Darwinian evolution of humans [32]. The
timeframe over which this significant genetic population
change occurred is roughly equivalent to the time over
which the model predicts global PatO2 to halve, and offers
some insight into how quickly humankind might be able to
adapt to the oncoming hypoxic selection pressure.
Any predictions about the nature of the human race in an
oxygen-deplete future using the genetics of present-day
high altitude populations is hampered by the fact that dif-
ferent genes appear to have undergone positive selection in
each, with no overlap in the variants expressed by the
Tibetans, Andeans, or Ethiopian highlanders [33]. Geno-
mic analysis of Andean populations has revealed at least 40
candidate genes involved in the HIF pathway or hypoxia-
related genes, including PRKAA1 (which codes for a
subunit of adenosine monophosphate-activated protein
kinase, and may influence fetal growth) [33, 34]. Natural
selection in many genes involved in the same pathways has
been demonstrated in high-altitude Tibetans, but the
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specific genes are at different loci or constitute different
variants, such as EGLN1 (which encodes prolyl hydroxy-
lase 2, the oxygen-dependent modulator of the HIF alpha
subunits [35]). Ethiopian highlanders show positive selec-
tion in different genes again, this time including
BHLHE41, which may be both a target and a modifier of
HIF-1 alpha [33, 36]. One possibility is that different
populations have followed different paths towards hypoxic
adaptation, influenced by other environmental variables in
each location (such as temperature or food availability),
and population factors such as the genetic variation in the
original settlers (contributing to genetic drift) and access to
other gene pools (contributing to genetic flow). A second
explanation is that they represent different time points on
the same journey towards an optimally adapted phenotype,
with duration and degree of hypoxic exposure different in
each region. If we accept the second explanation, then the
Tibetans, exposed to the greatest degree of hypoxic stress
for the longest time, would represent the current pinnacle
of long-term hypoxic adaptation. This is corroborated by
the fact that Tibetans have a lower incidence of CMS and
IUGR than their shorter-resident Andean counterparts [20].
The nature and rate of human adaptation to future atmo-
spheric hypoxia will depend on stochastic events and
making predictions is dogged by uncertainty, but the rate of
oxygen decline that is projected by the parabolic model
(PatO2 falling by 50% over the next 3500 years) may not
provide sufficient time for the development of a Tibetan
phenotype, but perhaps just enough to allow an Andean
pattern of traits to emerge.
Hypoxia survival limits and human extinction
Even with genetic and phenotypic adaptation, the parabolic
decline described by this mathematical model predicts a
scenario in which atmospheric oxygen concentration falls
to levels below the threshold where human survival and
reproduction may be sustained. Defining this point in terms
of oxygen concentration is difficult, and our hypothesis is
based on the highest elevations known to sustain lifelong
human habitation. The highest permanent settlement in the
present day is the Peruvian village of La Riconada, at an
altitude of 5100 m, which has around 30,000 inhabitants
[37]. Native villagers have survived there for at least
40 years and current residents have successfully gone
through child birth to create the next generation at this
altitude [38], however, it is not known whether the birth
rate can sustain this population indefinitely. The highest
permanent settlement on record is the (now abandoned)
Chilean mining village of Quilcha (5340 m), which was
discovered by the 1935 International High Altitude Expe-
dition to Chile [39]. It has been argued that this represents
the upper limit of long-term human habitation, because the
residents chose to sleep at this elevation and make a daily
ascent to the mine above. PatO2 at the Quilcha settlement is
11.3 kPa (slightly higher than 50% of the current PatO2 at
sea level). The parabolic deoxygenation model described
here predicts that PatO2 at sea level will reach this
threshold in *3600 years from now. During this time, the
human species is likely to undergo further positive selec-
tion for physiological phenotypes conveying survival
advantage in hypoxic conditions. Studies of high-altitude
residents tell us that while such adaptations may enable us
to function relatively well in an atmosphere that contains
just over half the oxygen we breathe today; many will
suffer the long-term consequences. Higher rates of mater-
nal pre-eclampsia and death, increased perinatal mortality,
low birth-weights (and the myriad consequences of this in
adulthood) and escalating pulmonary disease will curtail
life expectancy and population growth. Those individuals
with independent comorbidities, particularly chronic res-
piratory and cardiac disease, may suffer exacerbation of
their symptoms, reduced function, and reduced length of
life. Highlanders may be forced to descend as life becomes
intolerable at hypobaric elevations, therefore reducing the
Table 1 Physiological responses to sustained exposure to hypobaric hypoxia in different native populations (in comparison to values seen at sea
level) [29, 46, 47]. Adapted from [33]
Phenotype Andean Tibetan Ethiopian
Resting ventilation No increase 50% higher Not reported
Hypoxic ventilatory response Blunted (low) Similar to sea level (high) Not reported
Arterial oxygen saturation Elevated No increase Elevated
Hemoglobin concentration Elevated No increase (up to 4000 m) No increase (up to 4000 m)
Pulmonary arterial pressure Elevated Minimal increase Elevated
Nitric oxide levels Elevated Markedly elevated Not reported
Birth weight Elevated Elevated Not reported
CMS incidence Frequent Rare Very rare
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surface of Earth that we can populate. The burden of ill
health will begin to overwhelm the capability of healthcare
services. The last prevailing human phenotypes may
resemble those of current high-altitude populations: with
enhanced abilities to extract precious oxygen from the
atmosphere or deliver it to the tissues, and perhaps superior
cellular mechanisms to improve efficiency of oxygen use
and defend against hypoxic stress.
It is important to stress that the parabolic model described
here is mathematical rather than geophysical [5]. Other
authors have disputed the idea that global deoxygenation on
a catastrophic scale is possible [40]. One of the key reasons
cited for this is that the determining factor in global oxygen
decline is fossil fuel usage and current estimates predict that
oil, coal, and gas stocks will last 35, 107, and 37 years,
respectively [41]. Thus, is it plausible that the increased
fossil fuel usage in recent years has caused a temporary
acceleration of the deoxygenation phenomenon, which will
resolve once reserves have been exhausted. This scenario
would predict a very different decline in atmospheric oxygen
from the one we have described, with a fall of only a fraction
of a percent in 4400 years [42]. Consensus in this area has not
yet been achieved, but the need to understand the limits of
long-term human survival under progressively hypoxic
conditions cannot be questioned, whether we are considering
the persistence of the human race in the mathematical model
discussed here, or other contexts in which atmospheric
oxygen may become scarce, such as future long-term space
expeditions. Other environmental changes may also impact
the ability of humans to acclimatize to hypoxia during global
deoxygenation and these include the rise in both temperature
and concentration of carbon dioxide. It is hard to predict the
precise effect of these additional physiological stressors but
both are likely to reduce further our chances of long-term
survival. In particular, rising carbon dioxide levels could
lead to metabolic problems if individuals fail to adapt to this
adequately. High blood carbon dioxide levels (hypercarbia)
can cause acidosis, hypertension, and tachycardia. Those
with underlying lung chronic disease may suffer greatest
from this. In a simple, short-term experimental model of
Earth’s atmosphere, a novel experiment that used plants to
generate oxygen and consume carbon dioxide in a sealed
hypoxic chamber noted a high carbon concentration (0.66%)
towards the end of the 48-h experiment [43].
The atmospheric changes will also impact other animals
on Earth, and failure to adapt will result in extinction both
on land and in the seas and oceans. All aerobic life forms
will suffer as oxygen is removed from the atmosphere. In
addition, plant metabolism may also be detrimentally
affected. Already, the rising carbon dioxide concentration
has been predicted to reduce the rate of photorespiration,
and a falling oxygen concentration may exacerbate this.
While the overall effect of a reduction in photorespiration
remains unclear, we do know that complete removal of this
pathway could lead to metabolic disaster for the plants that
use it [44].
Conclusions
Progressive asphyxiation of the planet would ultimately lead
to the demise of humankind through escalating infant mor-
tality and eventually complete failure to reproduce. Perhaps
technological advancement could permit the continuation of
life within biospheres in the short term [45], but beyond this,
the outside world would become a barren and inhos-
pitable place. It is not possible to predict with certainty the
threshold value at which mass extinction becomes inevi-
table, but we have no evidence that humans can persist for
more than a generation in an atmosphere containing half the
amount of oxygen currently available at sea level, a situation
that, according to a new model, could be upon us in a few
thousand years. Unless the process of global deoxygenation
is reversed, either by increasing oxygen production or by
reducing its consumption, the human race, as obligate aer-
obes, will be left behind forever, our domination of this
planet a brief footnote in its history.
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